Songmao Zheng

机构：Johnson & Johnson (United States), Teradata (United States) · ORCID：0000-0002-7727-0928

发表论文 62 篇 · 总被引 1149 次 · h-index 18

代表论文

• Multivalent human antibody-centyrin fusion protein to prevent and treat Staphylococcus aureus infections (2023 · Cell Host & Microbe · 被引 27)
• A long‐acting GDF15 analog causes robust, sustained weight loss and reduction of food intake in an obese nonhuman primate model (2023 · Clinical and Translational Science · 被引 8)
• The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodies (2023 · CPT Pharmacometrics & Systems Pharmacology · 被引 7)
• Diversity in Clinical Pharmacology: A Call to Action (2023 · Clinical Pharmacology & Therapeutics · 被引 7)
• Abstract 2868: ADG206, an anti-CD137 agonistic POWERbody with tailor-made efficacy and safety profiles by strong crosslinking and tumor selective activation for single and combinational cancer immunotherapy (2022 · Cancer Research · 被引 5)
• Phase 1b/2 study of ADG106, a 4-1BB/CD137 agonist, in combination with toripalimab in patients with advanced solid tumors (2025 · iScience · 被引 4)